Internal Medicine
Evidence- and consensus-based guidelines for drug-drug interactions with anticancer drugs; A practical and universal tool for management.
12 Apr, 2022 | 10:02h | UTC
Opinion | Aligning incentives for improving diagnostic excellence.
12 Apr, 2022 | 09:54h | UTCAligning Incentives for Improving Diagnostic Excellence – JAMA (free for a limited period)
More data suggests the Omicron variant causes milder disease compared to the Delta variant.
12 Apr, 2022 | 09:49h | UTCRelated:
Perspective: Challenges in inferring intrinsic severity of the SARS-CoV-2 Omicron variant.
Early assessment of the clinical severity of the SARS-CoV-2 omicron variant in South Africa.
[Preprint] SARS-CoV-2 Omicron virus causes attenuated disease in mice and hamsters.
M-A: The clinical effect and safety of new preoperative fasting time guidelines for elective surgery.
12 Apr, 2022 | 09:51h | UTCRelated:
Does my hospitalized patient need an NPO-after-midnight order preoperatively?
Pro-Con Debate: 1- vs 2-Hour Fast for Clear Liquids Before Anesthesia in Children.
Aspirin for primary cardiovascular prevention in patients with diabetes: uncertainties and opportunities.
12 Apr, 2022 | 08:45h | UTCRelated Guideline:
Related Randomized Trials:
Randomized Trial: Aspirin for Primary Prevention of Cardiovascular Disease
Randomized Trial: Effects of Aspirin for Primary Prevention in Persons with Diabetes
Randomized Trial: Effect of Aspirin on All-Cause Mortality in the Healthy Elderly
Related Meta-Analysis:
Meta-Analysis: Efficacy and Safety of Aspirin for Primary Prevention of Cardiovascular Events
Related Opinions:
Aspirin for Primary Prevention: Is This the End of the Road?
Evidence evolving on aspirin as prevention – ACP Internist
Empyema: ED presentation, evaluation, and management.
12 Apr, 2022 | 08:44h | UTCEmpyema: ED Presentation, Evaluation, and Management – emDocs
Cohort Study: Insomnia linked to increased risk of recurrent cardiovascular events in patients with coronary heart disease.
12 Apr, 2022 | 08:36h | UTCCommentary: Insomnia is linked with recurrent heart events in coronary patients – European Society of Cardiology
Overview of diagnostic criteria and epidemiology of acute kidney injury and acute kidney disease in the critically ill patient.
12 Apr, 2022 | 08:30h | UTC
Review: Drug-induced interstitial lung disease.
12 Apr, 2022 | 08:29h | UTCDrug-induced interstitial lung disease – European Respiratory Review
Related: Systematic Review: Drug-Induced Interstitial Lung Disease
Drug-induced interstitial lung disease during cancer therapies: expert opinion on diagnosis and treatment.
12 Apr, 2022 | 08:27h | UTC
Prevention and management of postoperative ileus: a review of current practice.
12 Apr, 2022 | 08:20h | UTCPrevention and Management of Postoperative Ileus: A Review of Current Practice – Cureus
Clinical update on COVID-19 for the emergency and critical care clinician: Medical management.
11 Apr, 2022 | 02:00h | UTC
Keep the size of your waist to less than half of your height, updated NICE draft guideline recommends.
11 Apr, 2022 | 02:01h | UTCCommentaries:
Keep your waist to less than half your height, guidance says – BBC
Draft Guideline: Obesity: identification and classification of overweight and obesity – National Institute for Health and Care Excellence
RCT: For adults with HIV, a 4-days-on and 3-days-off treatment strategy is noninferior to standard treatment for maintaining viral suppression.
11 Apr, 2022 | 01:56h | UTCA 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial – The Lancet HIV (link to abstract – $ for full-text)
Commentary: Intermittent Treatment Strategy Is Effective for HIV – Consultant360
Commentaries on Twitter
New: A 4-days-on and 3-days-off maintenance treatment strategy for adults with HIV-1 (ANRS 170 QUATUOR): a randomised, open-label, multicentre, parallel, non-inferiority trial by Roland Landman and colleagues https://t.co/Tc2Rbo1ISt pic.twitter.com/YTV3XwfELo
— The Lancet HIV (@TheLancetHIV) February 3, 2022
In virologically suppressed people with HIV, randomization to intermittent ART (4 days on, 3 off) was non-inf. to daily dosing. Challenges what I thought about level of adherence needed. Is good adherence only needed during the viremic phase? https://t.co/lM8QZW0C9h
— David Serota (@serotavirus) March 16, 2022
Review: Atrial fibrillation.
11 Apr, 2022 | 01:57h | UTCAtrial fibrillation – Nature Reviews Disease Primers (if the link is paywalled, try this one)
Infographic: Atrial fibrillation – Nature Reviews Disease Primers (if the link is paywalled, try this one)
Commentary on Twitter
Get Primed on Atrial fibrillation with our NEW PrimeView! FREE to download this week! #AtrialFibrillation #AFibhttps://t.co/sI8Gx3yHmk pic.twitter.com/r6heFStAz5
— Nature Reviews Disease Primers (@DiseasePrimers) April 7, 2022
Review: Gastrointestinal post-acute COVID-19 syndrome.
11 Apr, 2022 | 01:49h | UTCGastrointestinal post-acute COVID-19 syndrome – Nature Reviews Gastroenterology & Hepatology
Commentary on Twitter
NEW! COMMENT
Gastrointestinal post-acute COVID-19 syndromehttps://t.co/SDAOnQSEp4#COVID19 #LongCovid pic.twitter.com/CUSoUt0azy
— Nature Reviews Gastroenterology & Hepatology (@NatRevGastroHep) April 9, 2022
RCT: Effect of Gram Stain–Guided initial antibiotic therapy on clinical response in patients with ventilator-associated pneumonia.
11 Apr, 2022 | 01:36h | UTCCommentary: Can Gram Stains Guide Antibiotics for Pneumonia in Critical Care? – Medscape (free registration required)
Commentary on Twitter
RCT found gram stain-guided antibiotic therapy for critically ill patients with VAP was noninferior to guideline-based antibiotics, with a reduction in antipseudomonal & antiMRSA use. https://t.co/1yoHO2pnER
— JAMA Network Open (@JAMANetworkOpen) April 8, 2022
UK clinical guideline for the prevention and treatment of osteoporosis.
11 Apr, 2022 | 01:33h | UTCUK clinical guideline for the prevention and treatment of osteoporosis – Archives of Osteoporosis
Guideline Synopsis: Management of chronic multisymptom illness.
11 Apr, 2022 | 01:29h | UTC
RCT: Efficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough.
11 Apr, 2022 | 01:22h | UTCEfficacy and safety of gefapixant, a P2X3 receptor antagonist, in refractory chronic cough and unexplained chronic cough (COUGH-1 and COUGH-2): results from two double-blind, randomised, parallel-group, placebo-controlled, phase 3 trials – The Lancet (link to abstract – $ for full-text)
Commentary on Twitter
For refractory chronic cough or unexplained chronic cough, gefapixant 45 mg twice per day is the first treatment to show efficacy with an acceptable safety profile in phase 3 clinical trials.
New study by Lorcan P McGarvey & colleagues: https://t.co/XnWM75s6lN pic.twitter.com/VyYyRgWTod
— The Lancet (@TheLancet) March 7, 2022
Effects of aspirin on dementia and cognitive function in diabetic patients: the ASCEND trial.
11 Apr, 2022 | 00:50h | UTCOriginal Study: Randomized Trial: Effects of Aspirin for Primary Prevention in Persons with Diabetes
Commentary on Twitter (images under a https://creativecommons.org/licenses/by/4.0/ license)
Does aspirin have an effect on dementia and cognitive function? Discover it in the EHJ!https://t.co/u5X1fxrULk#aspirin #dementia #CVD #ASCEND #trial #diabetes #cardiotwitter @escardio @ESC_Journals pic.twitter.com/TyrnUnf0MN
— EHJ Editor-in-Chief (@ehj_ed) April 8, 2022
Cohort Study: Use of Phosphodiesterase 5 Inhibitors linked to increased risk of ocular adverse events.
8 Apr, 2022 | 11:04h | UTCRisk of Ocular Adverse Events Associated With Use of Phosphodiesterase 5 Inhibitors in Men in the US – JAMA Ophthalmology (free for a limited period)
News Release: U.S. insurance claims show strong link between ED medications and vision problems – University of British Columbia
Commentaries:
Phase 4 Studies on Phosphodiesterase 5 Inhibitors – JAMA Ophthalmology (free for a limited period)
Could Viagra, Cialis Raise Men’s Odds for Eye Trouble? – HealthDay
M-A: Thrombosis patterns and clinical outcome of COVID-19 vaccine-induced immune thrombotic thrombocytopenia.
8 Apr, 2022 | 10:50h | UTCRelated:
Case series of Thrombosis with Thrombocytopenia Syndrome after Covid-19 vaccination in the US.
Review: Vaccine-induced immune thrombotic thrombocytopenia.
Vaccine induced immune thrombocytopenia and thrombosis: summary of NICE guidance.
Clinical features of vaccine-induced immune thrombocytopenia and thrombosis.
Vaccine-induced immune thrombotic thrombocytopenia: what we know and do not know.
Very rare cases of thrombosis with thrombocytopenia syndrome (TTS) after AstraZeneca vaccine: a global safety database analysis – the estimated rate of TTS after the first dose was 8.1 per million vaccinees; after the second dose, the estimated rate was 2.3 per million vaccinees. (several articles and resources on the subject)
M-A: Diagnostic performance of CO-RADS for Covid-19.
8 Apr, 2022 | 10:31h | UTC
Review | Chronic pain and infection: mechanisms, causes, conditions, treatments, and controversies.
8 Apr, 2022 | 10:27h | UTC


